<DOC>
	<DOCNO>NCT00549874</DOCNO>
	<brief_summary>The overall hypothesis test increased insulin resistance contribute abnormal cardiac blood flow regulation type 2 diabetic patient , reverse 6 month treatment rosiglitazone . The planned experimental approach utilize nuclear medicine technique evaluate whether administration rosiglitazone 6 month reverse regional deficit myocardial blood flow glucose utilization type 2 diabetes randomize double blind control study . These study help elucidate potential rosiglitazone correct deficit myocardial blood flow complicate diabetes overall aim eventual prevention sudden cardiac death .</brief_summary>
	<brief_title>Effect Rosiglitazone Myocardial Blood Flow Regulation Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<mesh_term>Glyburide</mesh_term>
	<criteria>Type 2 diabetes 3075 year age less 1 % fluctuation HbA1c 3 month woman must contraception HbA1c 69 % willingness sign approve consent form Nursing mother , pregnant woman ( excluded negative pregnancy test ) . Subjects require insulin therapy ( &gt; 20 units/day ) convert sulfonylurea therapy without loss diabetes control . Patients history drug alcohol dependence last 5 year Patients preexist cardiovascular disease include coronary artery disease , heart attack , heart failure , abnormal heart rhythm , structural abnormality valve disease , peripheral vascular disease uncontrolled high blood pressure . Patients history high cholesterol require therapy . Patients severe systemic disease diabetes recognize complication neuropathy Patients currently take drug act blood vessel ( example hypertension ) Patients take antidepressant , drug medication know interfere uptake metabolism catecholamine ( stress hormone ) Patients poor renal function significant liver disease Patients history previous kidney , pancreas cardiac transplantation . Patients history `` severe hypoglycemia '' require assistance third party ketoacidosis require hospital admission within last 3 month . Patients lung disease example result chronic obstructive airway disease . Patients abnormal thyroid function test . Patients take systemic investigational drug ( especially neuropathy ) initiate new experimental insulin delivery device within 3 month start study . Patients history allergic reaction multiple drug biological product . Obese patient ( BMI great 35 ) . Patients refuse sign inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>insulin resistance</keyword>
	<keyword>type 2 diabetes</keyword>
	<keyword>myocardial perfusion</keyword>
	<keyword>nitrosative stress</keyword>
	<keyword>thiazolidinediones</keyword>
</DOC>